Elesta announces that the Chinese regulatory authority National Medical Products Administration (NMPA) has approved EchoLaser for use in prostatic diseases. This approval is a major achievement and represents a great opportunity for Elesta (distributed in China by... Leggi tutto
Practical Theoretical Course at the LXY Institute in MADRID!
The theoretical – practical course at the LXY Institute in Madrid, where EchoLaser TPLA played a central role as a treatment for IPB, ended. Discover more thanks to Dr. Pablo Garrido Abad! III Edición Curso Práctico en STUI y Patología Vesicoprostática basado en... Leggi tutto
